----

|                          |
|--------------------------|
|                          |  |
| 001-10315                | 63-0860407 |
| (Commission File Number) | (I.R.S. Employer Identification No.) |
|                     |   |

|        |
|--------|
|        |  |
| £ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|   |   |
| £ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|   |   |
| £ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|   |   |
| £ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

----

----

|         |                                              |
|---------|----------------------------------------------|
| • | Adjusted EBITDA of $506 to $516 million; and |

|         |                                                                                              |
|---------|----------------------------------------------------------------------------------------------|
| • | Earnings per share from continuing operations attributable to HealthSouth of $1.61 to $1.68. |

|         |                                                                                                                           |
|---------|---------------------------------------------------------------------------------------------------------------------------|
| • | Discharge growth of between 3% and 4% (includes the acquisition of Walton Rehabilitation Hospital on April 1, 2013); |

|         |                                                        |
|---------|--------------------------------------------------------|
| • | Revenue per discharge growth of between 2.3% and 2.6%; |

|         |                                                               |
|---------|---------------------------------------------------------------|
| • | Revenue growth before sequestration of between 4.9% and 6.2%; |

|         |                                                                                                                                                           |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Sequestration impact of decrease in net operating revenues of approximately $28 million and decrease in Adjusted EBITDA of approximately $25 million; and |

|         |                                                                                                                                                       |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Operating expenses, as a percent of net operating revenues, generally consistent with, or in some cases lower than, the final three quarters of 2012. |

----

----

|                                                     |
|-----------------------------------------------------|
|                                                     |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                | Three Months Ended |   |   |   |   |   |   |   |   |   |   |
|                                                | March 31, |   | Year Ended December 31, |
|                                                | 2013 |   | 2012 |   | 2012 |   | 2011 |   | 2010 |   | 2009 |   | 2008 |
|                                                | (In Millions) |
| Net cash provided by operating activities           | $ | 121.4 |  |   | $ | 81.0 |  |   | $ | 411.5 |  |   | $ | 342.7 |  |   | $ | 331.0 |  |   | $ | 406.1 |  |   | $ | 227.2 |  |
| Provision for doubtful accounts                     | (7.4 | ) |   | (6.3 | ) |   | (27.0 | ) |   | (21.0 | ) |   | (16.4 | ) |   | (30.7 | ) |   | (23.0 | ) |
| Professional fees—accounting, tax, and legal  | 1.4 |  |   | 3.6 |  |   | 16.1 |  |   | 21.0 |  |   | 17.2 |  |   | 8.8 |  |   | 44.4 |  |
| Interest expense and amortization of debt           |   |   |   |   |   |   |   |   |   |   |   |   |   |
| discounts and fees                                  | 24.2 |  |   | 23.3 |  |   | 94.1 |  |   | 119.4 |  |   | 125.6 |  |   | 125.7 |  |   | 159.3 |  |
| UBS Settlement proceeds, gross                      | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | (100.0 | ) |   | — |  |
| Equity in net income of nonconsolidated             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| affiliates                                          | 2.9 |  |   | 3.3 |  |   | 12.7 |  |   | 12.0 |  |   | 10.1 |  |   | 4.6 |  |   | 10.6 |  |
| Net income attributable to noncontrolling interests |   |   |   |   |   |   |   |   |   |   |   |   |   |
| in continuing operations                            | (14.6 | ) |   | (12.6 | ) |   | (50.9 | ) |   | (47.0 | ) |   | (40.9 | ) |   | (33.3 | ) |   | (29.8 | ) |
| Amortization of debt discounts and fees             | (1.0 | ) |   | (0.9 | ) |   | (3.7 | ) |   | (4.2 | ) |   | (6.3 | ) |   | (6.6 | ) |   | (6.5 | ) |
| Distributions from nonconsolidated affiliates       | (3.4 | ) |   | (3.3 | ) |   | (11.0 | ) |   | (13.0 | ) |   | (8.1 | ) |   | (8.6 | ) |   | (10.9 | ) |
| Current portion of income tax expense (benefit)     | 1.8 |  |   | 2.1 |  |   | 5.9 |  |   | 0.6 |  |   | 2.9 |  |   | (7.0 | ) |   | (72.8 | ) |
| Change in assets and liabilities                    | 13.0 |  |   | 36.9 |  |   | 60.7 |  |   | 49.9 |  |   | 2.8 |  |   | (2.1 | ) |   | 50.6 |  |
| Net premium paid on bond issuance/redemption        | — |  |   | — |  |   | 1.9 |  |   | 22.8 |  |   | — |  |   | — |  |   | — |  |
| Change in government, class action,                 |   |   |   |   |   |   |   |   |   |   |   |   |   |
| and related settlements liability                   | — |  |   | — |  |   | (2.6 | ) |   | (8.5 | ) |   | 2.9 |  |   | 11.2 |  |   | 7.4 |  |
| Cash used in (provided by) operating activities     |   |   |   |   |   |   |   |   |   |   |   |   |   |
| of discontinued operations                          | 0.7 |  |   | (0.4 | ) |   | (2.0 | ) |   | (9.1 | ) |   | (13.2 | ) |   | (5.7 | ) |   | (32.5 | ) |
| Other                                               | 0.3 |  |   | 0.3 |  |   | 0.2 |  |   | 0.6 |  |   | 2.0 |  |   | 1.3 |  |   | (1.4 | ) |
| Adjusted EBITDA                                     | $ | 139.3 |  |   | $ | 127.0 |  |   | $ | 505.9 |  |   | $ | 466.2 |  |   | $ | 409.6 |  |   | $ | 363.7 |  |   | $ | 322.6 |  |

----

----

----

|        |
|--------|
|        |  |  |
|   |   |   |
| By:    | /S/   JOHN P. WHITTINGTON |
|   | Name: | John P. Whittington |
|   | Title: | Executive Vice President, General Counseland Corporate Secretary |